Literature DB >> 8126496

Lymphomatous meningitis in AIDS-related systemic non-Hodgkin's lymphoma: a report of eight cases.

R H Enting1, R A Esselink, P Portegies.   

Abstract

Meningeal involvement occurred in eight (22%) of 36 adult patients with AIDS-related systemic non-Hodgkin's lymphoma, seen over a 10-year period. Clinical symptoms consisted of cranial nerve palsies, radicular involvement, headache or diffuse encephalopathy. CSF examination established the diagnosis in all cases. Systemic disease had been diagnosed seven to 33 weeks before lymphomatous meningitis in six patients, whereas in the remaining two patients diagnoses of systemic and meningeal disease were made simultaneously. All patients had intermediate or high grade lymphomas and widespread disease. In contrast to non-AIDS related lymphomas, bone marrow involvement at initial staging cannot be used to select patients for prophylactic treatment, as seven of our eight patients had no initial bone marrow involvement. In this retrospective review, prognosis of lymphomatous meningitis was extremely poor, with a mean survival of only five weeks. Survival of patients with systemic lymphoma who eventually developed lymphomatous meningitis was 4.0 months compared with 7.2 months for those who did not. Lymphomatous meningitis appears to have the worst outcome of all AIDS-related neurological complications, regardless of treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8126496      PMCID: PMC1072440          DOI: 10.1136/jnnp.57.2.150

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

2.  Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy.

Authors:  M A Bermudez; K M Grant; R Rodvien; F Mendes
Journal:  Am J Med       Date:  1989-01       Impact factor: 4.965

3.  Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).

Authors:  D M Knowles; G A Chamulak; M Subar; J S Burke; M Dugan; J Wernz; C Slywotzky; G Pelicci; R Dalla-Favera; B Raphael
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

4.  AIDS-associated non-Hodgkin's lymphoma in San Francisco.

Authors:  L D Kaplan; D I Abrams; E Feigal; M McGrath; J Kahn; P Neville; J Ziegler; P A Volberding
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272

5.  Stimulation by propylthiouracil of the hexose monophosphate shunt in human polymorphonuclear leucocytes during phagocytosis.

Authors:  M F Tsan; P A McIntyre
Journal:  Br J Haematol       Date:  1975-10       Impact factor: 6.998

6.  Central nervous system involvement in haematological malignancies.

Authors:  T Sheehan; R J Cuthbert; A C Parker
Journal:  Clin Lab Haematol       Date:  1989

7.  Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome.

Authors:  J L Ziegler; J A Beckstead; P A Volberding; D I Abrams; A M Levine; R J Lukes; P S Gill; R L Burkes; P R Meyer; C E Metroka
Journal:  N Engl J Med       Date:  1984-08-30       Impact factor: 91.245

8.  Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?

Authors:  G J Johnson; M M Oken; J R Anderson; M J O'Connell; J H Glick
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

9.  CNS involvement in the non-Hodgkin's lymphomas.

Authors:  L J Levitt; D M Dawson; D S Rosenthal; W C Moloney
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

10.  Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis.

Authors:  J P Litam; F Cabanillas; T L Smith; G P Bodey; E J Freireich
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.